ElevenFlo checks this case against the court docket on a schedule and records the entries it finds, entry by entry.
Case details
Case No.
23-10605
Court
Delaware
Judge
J. Kate Stickles
Petition date
May 9, 2023
Industry
Healthcare
Recent court activity
12 recent docket entries recorded. These entries come from the court docket. The filing documents are not available in ElevenFlo yet.
Dkt. 451Order Further Extending Claims Objection Deadline (Related Doc # [448])(related document(s)[448]) Order Signed on 5/11/2026. (AJL)May 11, 2026
Dkt. 450Certificate of No Objection Regarding Motion of the Liquidating Trustee for Entry of an Order Further Extending Claims Objection Deadline (related document(s)[448]) Filed by David W. Carickhoff. (Root, Alan)May 6, 2026
Dkt. 448Motion to Extend Motion of the Liquidating Trustee for Entry of an Order Further Extending Claims Objection Deadline Filed by David W. Carickhoff. Hearing scheduled for 6/2/2026 at 11:00 AM at US Bankruptcy Court, 824 Market St., 5th Fl., Courtroom #6, Wilmington, Delaware. Objections due by 5/5/2026. (Attachments: # (1) Exhibit 1 # (2) Notice) (Root, Alan)Apr 21, 2026
Dkt. 447Order Scheduling Omnibus Hearings. (Related document(s)[446]) Omnibus Hearings scheduled for 6/2/2026 at 11:00 AM US Bankruptcy Court, 824 Market St., 5th Fl., Courtroom #6, Wilmington, Delaware. Signed on 4/21/2026. (AJL)Apr 21, 2026
Dkt. 446Certification of Counsel Regarding Scheduling of Omnibus Hearing Date Filed by David W. Carickhoff. (Attachments: # (1) Proposed Form of Order) (Root, Alan)Apr 21, 2026
Dkt. 6Order Approving Stipulation for an Extension of Time for Defendants Amneal Pharmaceuticals, Inc. and Impax Laboratories, LLC to Respond to Complaint (related document(s)[4]) Order Signed on 6/5/2025. (Attachments: # (1) Declaration 1 - Stipulation) (AJL)Jun 5, 2025
Dkt. 5Corporate Ownership Statement pursuant to F.R.B.P. 7007.1(a) Filed by Amneal Pharmaceuticals, Inc., Impax Laboratories, LLC. (Listwak, Kenneth)Jun 4, 2025
Dkt. 4Certification of Counsel Regarding Stipulation for an Extension of Time for Defendants Amneal Pharmaceuticals, Inc. and Impax Laboratories, LLC to Respond to Complaint (related document(s)[1], [3]) Filed by Amneal Pharmaceuticals, Inc., Impax Laboratories, LLC. (Attachments: # (1) Exhibit A - Proposed Order) (Listwak, Kenneth)Jun 4, 2025
Dkt. 443Certificate of Mailing Re: 1) Order (A) Approving the Orpha Labs Sale to Baar Therapeutics AG; (B) Authorizing Assumption and Assignment of Certain Executory Contracts in Connection with the Sale; and (C) Granting Related Relief; and 2) Notice of Amended Agenda of Matters Scheduled for Hearing on May 28, 2025, at 10:00 a.m. (Eastern Time). Filed by Epiq Corporate Restructuring, LLC. (related document(s)[439], [440]) (Garabato, Sid)Jun 2, 2025
Dkt. 439Order (A) Approving the Orpha Labs Sale to Baar Therapeutics AG; (B) Authorizing Assumption and Assignment of Certain Executory Contracts in Connection with the Sale; and (C) Granting Related Relief (Related Doc # [425])(related document(s)[425], [437]) Order Signed on 5/27/2025. (Attachments: # (1) Exhibit 1) (AJL)May 27, 2025
Dkt. 438Certification of Counsel Regarding Order (A) Approving the Orpha Labs Sale to Baar Therapeutics AG; (B) Authorizing Assumption and Assignment of Certain Executory Contracts in Connection with the Sale; and (C) Granting Related Relief (related document(s)[425], [436]) Filed by David W. Carickhoff. (Attachments: # (1) Exhibit A # (2) Exhibit B) (Sarna, Matthew)May 27, 2025
Dkt. 437Declaration in Support - Declaration of David W. Carickhoff, Liquidating Trustee of the Vyera Liquidating Trust and Sole Director of Orpha Labs AG, in Support of the Motion of the Liquidating Trustee for Entry of an Order (A) Approving the Orpha Labs Sale to Baar Therapeutics AG; (B) Authorizing Assumption and Assignment of Certain Executory Contracts in Connection with the Sale; and (C) Granting Related Relief (related document(s)[425]) Filed by David W. Carickhoff. (Sarna, Matthew)May 27, 2025
